Grissom Exits Boston Scientific Beltway; Polymer Traffic To Continue
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific VP-Federal Affairs, Reimbursement & Outcomes Planning Randel Richner will direct Washington, D.C. operations on a temporary basis, now that Tom Grissom has left the firm
You may also be interested in...
DRG Split For Complex DES May Herald Multi-Vessel Payment Reforms
CMS remains open to considering whether inpatient diagnosis-related groups (DRGs) for drug-eluting stents should reflect differences in the number of stents implanted and/or vessels treated
CMS Issues “Coverage With Evidence Development” Draft Guidance
CMS' "coverage with evidence development" (CED) draft guidance appears to venture into FDA's traditional jurisdiction of evaluating safety and effectiveness
AdvaMed’s Bailey Gets Makeover As Cosmetic Head; Swift Search Anticipated
AdvaMed member companies who are not represented on the group's executive search committee are circulating a list of potential replacements for President Pam Bailey